Mr Paul Thiruchelvam

Consultant in breast and reconstructive surgery

Primary medical qualifications:

MB BS PhD

GMC number:

4729606

Breast surgery

Paul Thiruchelvam

Background

Mr Paul Thiruchelvam is a consultant oncoplastic breast surgeon at Imperial College Healthcare NHS Trust and an honorary senior lecturer in surgery at Imperial College London. He graduated from Imperial College in 2000 and undertook his surgical training in the north west Thames rotation, during which time he rotated through the breast units at Imperial College and The Royal Marsden Hospital. He completed his surgical training as a national oncoplastic group (TIG) fellow at the Nottingham Breast Institute, where he undertook research mapping the anatomy of chest wall perforator flaps (lateral intercostal artery perforator (LICAP) and lateral thoracic artery perforator (LTAP)) in partial and total breast reconstruction.

Mr Thiruchelvam has undertaken travelling fellowships to the MD Anderson, Mayo Clinic, and Memorial Sloan Kettering Cancer Centers. He was awarded a Winston Churchill Memorial Fellowship in 2016, visiting the Netherlands, United States and Japan to observe the use of axillary reverse mapping (ARM) and lymphatic microsurgical preventing healing approach (LYMPHA) in primary lymphoedema prevention. He is actively involved in lymphedema prevention. As a member of the expert panel on breast cancer related lymphoedema, he was involved in drafting best practice guidelines for the American Society of Breast Surgeons.

He received his PhD in molecular oncology from Imperial College in 2010, under supervision from Professors Simak Ali, Laki Buluwela and Charles Coombes. He was awarded the first joint clinical research fellowship from the Royal College of Surgeons and Cancer Research UK to fund his research. He is actively involved in clinical trials, including the multi-centre PRADA trial.

Expertise

Breast diagnostics, oncoplastic breast surgery, partial breast reconstruction, risk reduction breast surgery, breast reconstruction, benign breast disease, breast cancer related lymphoedema – primary prevention, surveillance and treatment